A patient with CHD can recover to do amazing things, and this has motivated me to dedicate my life to such warriors.

MEDIA

Caregiver Profile

Caregiver Profile

Meet Dr. Sitaram Emani

MEDICAL SERVICES

Departments

Programs

Languages

  • English

EDUCATION

Undergraduate Degree

  • Northwestern University , 1993 , Evanston , IL

Medical School

  • Harvard Medical School , 1997 , Boston , MA

Residency

General and Thoracic Surgery
  • Duke University Medical Center , 2005 , Durham , NC

Residency

Cardiothoracic Surgery
  • Duke University Medical Center , 2006 , Durham , NC

Fellowship

  • Boston Children's Hospital , 2007 , Boston , MA

Philosophy of Care

Although originally an engineer by training, I found my true inspiration to be children and adults with congenital heart disease.

With just a little help from doctors and surgeons, a patient with CHD can recover to do amazing things, and this has motivated me to dedicate my life to such “warriors”.  I try to combine my experience as an engineer to bring new technology and innovative solutions to difficult problems, but find the greatest satisfaction in seeing a child run, laugh, and play even after major surgery. My adult patients with congenital heart disease were the trailblazers for our field as they were among the first to undergo many of the surgeries we perform today.  But they may need further surgeries later in adulthood, and have unique needs that we address with our combined adult congenital heart program. My research and device development work is totally motivated by my CHD warriors young and old, as we find ways to solve complex problems together.

PROFESSIONAL HISTORY

Following completion of training in adult cardiothoracic surgery and pediatric cardiothoracic surgery, I joined the staff at Boston Children’s Hospital.  I am the surgical director for the complex biventricular repair program, and adult congenital heart program.  My clinical expertise also includes valve repair and replacement strategies, neonatal heart surgery, and minimally invasive surgery for children.  My research efforts include strategies to “grow” a left heart – including stem cell therapy - in patients with borderline left heart who otherwise would undergo single ventricle palliation.  A major problem in children with heart valve disease is the lack of a valve that can grow as a child grows.  This motivated me to pursue a design of expandable valve technologies, to reduce the need for reoperation in children.  Additional research interests include use of 3-D printing for surgical planning and understanding the clotting system in children after heart surgery. 

 

Dr. Emani serves as an expert for the Department of Cardiac Surgery for Boston Children's Hospital Precision Medicine Service. For more information about the Precision Medicine Service please visit bostonchildrens.org/precisionmed.

CERTIFICATIONS

  • American Board of Thoracic Surgery, Congenital Heart Surgery
  • American Board of Thoracic Surgery

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. A Multi-Mode System for Myocardial Functional and Physiological Assessment during Ex Situ Heart Perfusion. J Extra Corpor Technol. 2020 Dec; 52(4):303-313. View abstract
  2. Autologous mitochondrial transplantation for cardiogenic shock in pediatric patients following ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2020 Dec 01. View abstract
  3. Commentary: Another Way to Avoid the Fontan in Patients With Complex Transposition of the Great Arteries. Semin Thorac Cardiovasc Surg. 2020 Nov 09. View abstract
  4. Comparison of outcomes following thoracoscopic versus thoracotomy closure for persistent patent ductus arteriosus. Cardiol Young. 2020 Oct; 30(10):1433-1438. View abstract
  5. Mitochondrial transplantation for myocardial protection in ex-situ?perfused hearts donated after circulatory death. J Heart Lung Transplant. 2020 Jun 29. View abstract
  6. Experience and Outcomes of Surgically Implanted Melody Valve in the Pulmonary Position. Ann Thorac Surg. 2021 Mar; 111(3):966-972. View abstract
  7. Single Ventricle With Atrioventricular Valve Regurgitation-Ongoing Challenges. Ann Thorac Surg. 2021 02; 111(2):670-671. View abstract
  8. Platelet Inhibition With IV Glycoprotein IIb/IIIa Inhibitor to Prevent Thrombosis in Pediatric Patients Undergoing Aortopulmonary Shunting. Pediatr Crit Care Med. 2020 06; 21(6):e354-e361. View abstract
  9. Revisiting prosthesis choice in mitral valve replacement in children: Durable alternatives to traditional bioprostheses. J Thorac Cardiovasc Surg. 2020 May 31. View abstract
  10. Letter by McCully et al Regarding Article, "Mitochondria Do Not Survive Calcium Overload". Circ Res. 2020 04 10; 126(8):e56-e57. View abstract
  11. Reply: There is no "one-size-fits-all" in Fontan surgery! J Thorac Cardiovasc Surg. 2020 07; 160(1):e10. View abstract
  12. Reply: Intracoronary Delivery of Mitochondria to Prevent Ischemia-Reperfusion Injury: Challenging Pathway From Bench to Bedside. JACC Basic Transl Sci. 2020 Feb; 5(2):209. View abstract
  13. Multipotency of mouse trophoblast stem cells. Stem Cell Res Ther. 2020 02 13; 11(1):55. View abstract
  14. Looking Ahead in Pediatric Heart Surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2020; 23:1. View abstract
  15. Expandable Valves, Annuloplasty Rings, Shunts, and Bands for Growing Children. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2020; 23:17-23. View abstract
  16. Intraoperative Coronary Artery Imaging for Planning. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2020; 23:11-16. View abstract
  17. Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery Practice. J Extra Corpor Technol. 2019 Dec; 51(4):221-226. View abstract
  18. Fontan with lateral tunnel is associated with improved survival compared with extracardiac conduit. J Thorac Cardiovasc Surg. 2020 04; 159(4):1480-1491.e2. View abstract
  19. Flow disturbances and the development of endocardial fibroelastosis. J Thorac Cardiovasc Surg. 2020 Feb; 159(2):637-646. View abstract
  20. Repair of double outlet right ventricle: Midterm outcomes. J Thorac Cardiovasc Surg. 2019 Aug 30. View abstract
  21. Long-term Surgical Prognosis of Primary Supravalvular Aortic Stenosis Repair. Ann Thorac Surg. 2019 10; 108(4):1202-1209. View abstract
  22. High-dose heparin is associated with higher bleeding and thrombosis rates in pediatric patients following cardiac surgery. J Thorac Cardiovasc Surg. 2019 10; 158(4):1199-1206. View abstract
  23. Lessons learned from Melody valve retrieved at transplantation. J Thorac Cardiovasc Surg. 2019 08; 158(2):e74-e75. View abstract
  24. Flow disturbances and progression of endocardial fibroelastosis - a case report. Cardiovasc Pathol. 2019 Sep - Oct; 42:1-3. View abstract
  25. Novel Coagulation Analyzers in Development: A Glimpse toward the Future of Microfluidics. Semin Thromb Hemost. 2019 Apr; 45(3):302-307. View abstract
  26. Repair of Tetralogy of Fallot - Progress or Just a Moving Target? Semin Thorac Cardiovasc Surg. 2019; 31(3):505-506. View abstract
  27. Mechanical Properties of Autologous Pericardium Change With Fixation Time: Implications for Valve Reconstruction. Semin Thorac Cardiovasc Surg. 2019; 31(4):852-854. View abstract
  28. Surgical Atrioventricular Valve Replacement With Melody Valve in Infants and Children. Circ Cardiovasc Interv. 2018 11; 11(11):e007145. View abstract
  29. Evaluation of Placental Mesenchymal Stem Cell Sheets for Myocardial Repair and Regeneration. Tissue Eng Part A. 2019 06; 25(11-12):867-877. View abstract
  30. Valve-sparing repair in tetralogy of Fallot: Does valve biology determine long-term outcome? J Thorac Cardiovasc Surg. 2018 08; 156(2):782-784. View abstract
  31. Venous valve saves the day for a patient with single ventricle and atrioventricular valve disease. J Thorac Cardiovasc Surg. 2018 12; 156(6):e215-e216. View abstract
  32. Pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals: collateral vessel disease burden and unifocalisation strategies. Cardiol Young. 2018 Sep; 28(9):1091-1098. View abstract
  33. Complications of Durable Left Ventricular Assist Device Therapy. Crit Care Clin. 2018 Jul; 34(3):465-477. View abstract
  34. Editorial commentary: Technology to treat heart failure: Friend or foe? Trends Cardiovasc Med. 2018 10; 28(7):489-490. View abstract
  35. Thromboelastography Is Associated With Surrogates for Bleeding After Pediatric Cardiac Operations. Ann Thorac Surg. 2018 09; 106(3):799-806. View abstract
  36. An anticoagulation protocol for use after congenital cardiac surgery. J Thorac Cardiovasc Surg. 2018 07; 156(1):343-352.e4. View abstract
  37. Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2018 07; 156(1):332-340.e1. View abstract
  38. Staged ventricular recruitment in patients with borderline ventricles and large ventricular septal defects. J Thorac Cardiovasc Surg. 2018 07; 156(1):254-264. View abstract
  39. Mitochondrial transplantation: applications for pediatric patients with congenital heart disease. Transl Pediatr. 2018 Apr; 7(2):169-175. View abstract
  40. Cell-Based Therapy With Cardiosphere-Derived Cardiocytes: A New Hope for Pediatric Patients With Single Ventricle Congenital Heart Disease? Circ Res. 2018 03 30; 122(7):916-917. View abstract
  41. Flow Preservation of Umbilical Vein for Autologous Shunt and Cardiovascular Reconstruction. Ann Thorac Surg. 2018 06; 105(6):1809-1818. View abstract
  42. Does recipient work status pre-transplant affect post-heart transplant survival? A United Network for Organ Sharing database review. J Heart Lung Transplant. 2018 05; 37(5):604-610. View abstract
  43. Anticoagulation management following left ventricular assist device implantation is similar across all provider strategies. Interact Cardiovasc Thorac Surg. 2018 01 01; 26(1):60-65. View abstract
  44. Valve-sparing repair with intraoperative balloon dilation in tetralogy of Fallot: Midterm results and therapeutic implications. J Thorac Cardiovasc Surg. 2018 03; 155(3):1163-1173.e4. View abstract
  45. Multicenter Evaluation of Octreotide as Secondary Prophylaxis in Patients With Left Ventricular Assist Devices and Gastrointestinal Bleeding. Circ Heart Fail. 2017 Nov; 10(11). View abstract
  46. Elevated preoperative von Willebrand factor is associated with perioperative thrombosis in infants and neonates with congenital heart disease. J Thromb Haemost. 2017 12; 15(12):2306-2316. View abstract
  47. Early intervention for lactate dehydrogenase elevation improves clinical outcomes in patients with the HeartMate II left ventricular assist device: Insights from the PREVENT study. J Heart Lung Transplant. 2018 01; 37(1):25-32. View abstract
  48. Right ventricular outflow tract reintervention after primary tetralogy of Fallot repair in neonates and young infants. J Thorac Cardiovasc Surg. 2018 02; 155(2):726-734. View abstract
  49. Getting to the Heart of the Matter: Review of Treatment of Cardiorenal Syndrome. Adv Chronic Kidney Dis. 2017 07; 24(4):261-266. View abstract
  50. Platelet testing to guide aspirin dose adjustment in pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2017 11; 154(5):1723-1730. View abstract
  51. Relationship Between Transfusion of Blood Products and the Incidence of Thrombotic Complications in Neonates and Infants Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2017 Dec; 31(6):1943-1948. View abstract
  52. Hemodynamic parameters predict adverse outcomes following biventricular conversion with single-ventricle palliation takedown. J Thorac Cardiovasc Surg. 2017 08; 154(2):572-582. View abstract
  53. Mitochondrial transplantation: From animal models to clinical use in humans. Mitochondrion. 2017 05; 34:127-134. View abstract
  54. Outcomes following thoracotomy or thoracoscopic vascular ring division in children and young adults. J Thorac Cardiovasc Surg. 2017 08; 154(2):607-615. View abstract
  55. Autologous mitochondrial transplantation for dysfunction after ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2017 07; 154(1):286-289. View abstract
  56. Photo-oxidized bovine pericardium in congenital cardiac surgery: single-centre experience. Interact Cardiovasc Thorac Surg. 2017 02 01; 24(2):240-244. View abstract
  57. Mitochondrial Transplantation in Myocardial Ischemia and Reperfusion Injury. Adv Exp Med Biol. 2017; 982:595-619. View abstract
  58. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices. Clin Transplant. 2017 02; 31(2). View abstract
  59. PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study. J Heart Lung Transplant. 2017 01; 36(1):1-12. View abstract
  60. Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes. J Thorac Cardiovasc Surg. 2017 02; 153(2):439-440. View abstract
  61. Left Main Coronary Artery Atresia in an Infant With Inclusion-Cell Disease. World J Pediatr Congenit Heart Surg. 2018 03; 9(2):246-250. View abstract
  62. Direct heart shunt placement for CSF diversion: technical note. J Neurosurg Pediatr. 2016 Dec; 25(6):663-666. View abstract
  63. Concept of an expandable cardiac valve for surgical implantation in infants and children. J Thorac Cardiovasc Surg. 2016 12; 152(6):1514-1523. View abstract
  64. Surgical reconstruction of semilunar valves in the growing child: Should we mimic the venous valve? A simulation study. J Thorac Cardiovasc Surg. 2017 02; 153(2):389-396. View abstract
  65. Outcome and performance of bioprosthetic pulmonary valve replacement in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2016 11; 152(5):1333-1342.e3. View abstract
  66. Assessment of the Melody valve in the mitral position in young children by echocardiography. J Thorac Cardiovasc Surg. 2017 01; 153(1):153-160.e1. View abstract
  67. Incidence and Predictors for Postoperative Thrombotic Complications in Children With Surgical and Nonsurgical Heart Disease. Ann Thorac Surg. 2016 Oct; 102(4):1360-7. View abstract
  68. Ring-reinforced Sano right ventricular to pulmonary artery conduit at Norwood stage I. Multimed Man Cardiothorac Surg. 2016; 2016. View abstract
  69. Operations for improving left ventricular diastolic function. Curr Opin Cardiol. 2016 Jan; 31(1):101-8. View abstract
  70. Successful heart transplantation using a donor heart afflicted by takotsubo cardiomyopathy. Proc (Bayl Univ Med Cent). 2016 Jan; 29(1):73-4. View abstract
  71. Expandable Valve for Pediatric Application Constructed From Human Venous Valved Conduit Within a Stent. Ann Thorac Surg. 2015 Dec; 100(6):2320-4. View abstract
  72. Neonatal Mitral Valve Repair in Biventricular Repair, Single Ventricle Palliation, and Secondary Left Ventricular Recruitment: Indications, Techniques, and Mid-Term Outcomes. Front Surg. 2015; 2:59. View abstract
  73. Hybrid Approach for Off-Pump Pulmonary Valve Replacement in Patients With a Dilated Right Ventricular Outflow Tract. Ann Thorac Surg. 2015 Nov; 100(5):e99-101. View abstract
  74. Outcomes and Short-Term Follow-Up in Complex Ross Operations in Pediatric Patients Undergoing Damus-Kaye-Stansel Takedown. Semin Thorac Cardiovasc Surg. 2016; 28(1):81-9. View abstract
  75. Invited Commentary. Ann Thorac Surg. 2015 Jun; 99(6):2164-5. View abstract
  76. Intravenous GPIIb/IIIa Inhibitor for Secondary Prevention of Shunt Thrombosis in a Pediatric Patient. Ann Thorac Surg. 2015 Jun; 99(6):e151-3. View abstract
  77. Left Ventricular Remodeling and Function in Children with Biventricular Circulation After Fetal Aortic Valvuloplasty. Pediatr Cardiol. 2015 Oct; 36(7):1502-9. View abstract
  78. Transcatheter balloon dilation for recurrent right ventricular outflow tract obstruction following valve-sparing repair of tetralogy of Fallot. Catheter Cardiovasc Interv. 2015 Oct; 86(4):692-700. View abstract
  79. Biventricular repair for common atrioventricular canal defect with parachute left atrioventricular valve. Eur J Cardiothorac Surg. 2016 Feb; 49(2):546-51; discussion 551-2. View abstract
  80. Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology. 2015 Apr; 122(4):746-58. View abstract
  81. Echocardiographic characteristics of annulo-leaflet mitral ring. J Am Soc Echocardiogr. 2015 May; 28(5):541-8. View abstract
  82. A method to account for variation in congenital heart surgery charges. Ann Thorac Surg. 2015 Mar; 99(3):939-46. View abstract
  83. Technical performance score as predictor for post-discharge reintervention in valve-sparing tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg. 2014; 26(4):297-303. View abstract
  84. Cardiac extracellular matrix-fibrin hybrid scaffolds with tunable properties for cardiovascular tissue engineering. Acta Biomater. 2015 Mar; 14:84-95. View abstract
  85. Ring-reinforced Sano conduit at Norwood stage I reduces proximal conduit obstruction. Ann Thorac Surg. 2015 Jan; 99(1):171-9. View abstract
  86. Aortic root translocation (Nikaidoh procedure): Intermediate follow-up and impact of conduit type. J Thorac Cardiovasc Surg. 2015 May; 149(5):1349-55. View abstract
  87. Cardiovascular magnetic resonance parameters associated with early transplant-free survival in children with small left hearts following conversion from a univentricular to biventricular circulation. J Cardiovasc Magn Reson. 2014 Oct 07; 16:73. View abstract
  88. Rare case of undiagnosed supracardiac total anomalous pulmonary venous return in an adult. Circulation. 2014 Sep 30; 130(14):1205-7. View abstract
  89. Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: postnatal outcomes of the first 100 patients. Circulation. 2014 Aug 19; 130(8):638-45. View abstract
  90. Durability of large diameter right ventricular outflow tract conduits in adults with congenital heart disease. Int J Cardiol. 2014 Aug 20; 175(3):455-63. View abstract
  91. Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2014 Sep; 148(3):810-4; discussion 814-6. View abstract
  92. Perinatal and infant outcomes of prenatal diagnosis of heterotaxy syndrome (asplenia and polysplenia). Am J Cardiol. 2014 Aug 15; 114(4):612-7. View abstract
  93. Takedown of cavopulmonary shunt at biventricular repair. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1506-11. View abstract
  94. Preliminary experience with porcine intestinal submucosa (CorMatrix) for valve reconstruction in congenital heart disease: histologic evaluation of explanted valves. J Thorac Cardiovasc Surg. 2014 Nov; 148(5):2216-4, 2225.e1. View abstract
  95. Valve-sparing aortic root replacement and remodeling with complex aortic valve reconstruction in children and young adults with moderate or severe aortic regurgitation. J Thorac Cardiovasc Surg. 2014 Jun; 147(6):1768-74. View abstract
  96. Stented bovine jugular vein graft (Melody valve) for surgical mitral valve replacement in infants and children. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1443-9. View abstract
  97. Tricuspid regurgitation or Ebsteinoid dysplasia of the tricuspid valve in congenitally corrected transposition: is valvuloplasty necessary at anatomic repair? J Thorac Cardiovasc Surg. 2014 Feb; 147(2):576-80. View abstract
  98. Hypercoagulability panel testing predicts thrombosis in neonates undergoing cardiac surgery. Am J Hematol. 2014 Feb; 89(2):151-5. View abstract
  99. Technical Performance Scores are strongly associated with early mortality, postoperative adverse events, and intensive care unit length of stay-analysis of consecutive discharges for 2 years. J Thorac Cardiovasc Surg. 2014 Jan; 147(1):389-94, 396.e1-396.e3. View abstract
  100. An extracorporeal membrane oxygenation cannulation curriculum featuring a novel integrated skills trainer leads to improved performance among pediatric cardiac surgery trainees. Simul Healthc. 2013 Aug; 8(4):221-8. View abstract
  101. Biventricular conversion after single ventricle palliation in patients with small left heart structures: short-term outcomes. Ann Thorac Surg. 2013 Oct; 96(4):1406-1412. View abstract
  102. Impact of age and duration of banding on left ventricular preparation before anatomic repair for congenitally corrected transposition of the great arteries. Ann Thorac Surg. 2013 Aug; 96(2):603-10. View abstract
  103. Predictors of reintervention after repair of interrupted aortic arch with ventricular septal defect. Ann Thorac Surg. 2013 Aug; 96(2):621-8. View abstract
  104. Hypercoagulability markers predict thrombosis in single ventricle neonates undergoing cardiac surgery. Ann Thorac Surg. 2013 Aug; 96(2):651-6. View abstract
  105. Inadequate technical performance scores are associated with late mortality and late reintervention. Ann Thorac Surg. 2013 Aug; 96(2):664-9. View abstract
  106. Factors associated with survival in patients who undergo peritoneal dialysis catheter placement following cardiac surgery. J Pediatr Surg. 2013 Jun; 48(6):1269-76. View abstract
  107. Biventricular conversion after single-ventricle palliation in unbalanced atrioventricular canal defects. Ann Thorac Surg. 2013 Jun; 95(6):2086-95; discussion 2095-6. View abstract
  108. Sexual function after left ventricular assist device. J Am Coll Cardiol. 2013 May 14; 61(19):2021-2. View abstract
  109. Strategies to maintain biventricular circulation in patients with high-risk anatomy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2013; 16(1):37-42. View abstract
  110. Novel microfluidic platform for automated lab-on-chip testing of hypercoagulability panel. Blood Coagul Fibrinolysis. 2012 Dec; 23(8):760-8. View abstract
  111. Patients with low compared with high body mass index gain more weight after implantation of a continuous-flow left ventricular assist device. J Heart Lung Transplant. 2013 Jan; 32(1):31-5. View abstract
  112. Characterizing peritoneal dialysis catheter use in pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2013 Aug; 146(2):334-8. View abstract
  113. Staged left ventricular recruitment after single-ventricle palliation in patients with borderline left heart hypoplasia. J Am Coll Cardiol. 2012 Nov 06; 60(19):1966-74. View abstract
  114. Modification of a stented bovine jugular vein conduit (melody valve) for surgical mitral valve replacement. Ann Thorac Surg. 2012 Oct; 94(4):e97-8. View abstract
  115. Surgical technical performance scores are predictors of late mortality and unplanned reinterventions in infants after cardiac surgery. J Thorac Cardiovasc Surg. 2012 Nov; 144(5):1095-1101.e7. View abstract
  116. Technical performance scores in congenital cardiac operations: a quality assessment initiative. Ann Thorac Surg. 2012 Oct; 94(4):1317-23; discussion 1323. View abstract
  117. A mathematical model of transitional circulation toward biventricular repair in hypoplastic left heart syndrome. Anesth Analg. 2012 Sep; 115(3):618-26. View abstract
  118. Improving left ventricular outflow tract obstruction repair in common atrioventricular canal defects. Ann Thorac Surg. 2012 Aug; 94(2):599-605; discussion 605. View abstract
  119. Dilation of the ascending aorta after balloon valvuloplasty for aortic stenosis during infancy and childhood. Am J Cardiol. 2012 Sep 01; 110(5):702-8. View abstract
  120. Pulmonary valve replacement function in adolescents: a comparison of bioprosthetic valves and homograft conduits. Ann Thorac Surg. 2012 Jun; 93(6):2007-16. View abstract
  121. Bare metal stenting for obstructed small diameter homograft conduits in the right ventricular outflow tract. Catheter Cardiovasc Interv. 2013 Jan 01; 81(1):E44-52. View abstract
  122. A comparison of human smooth muscle and mesenchymal stem cells as potential cell sources for tissue-engineered vascular patches. Tissue Eng Part A. 2012 May; 18(9-10):986-98. View abstract
  123. Options for prosthetic pulmonary valve replacement. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2012; 15(1):34-7. View abstract
  124. Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg. 2012 Feb; 143(2):352-60. View abstract
  125. Outcome after repair of cor triatriatum. Am J Cardiol. 2012 Feb 01; 109(3):412-6. View abstract
  126. Outcomes and risk factors for mortality in premature neonates with critical congenital heart disease. Pediatr Cardiol. 2011 Dec; 32(8):1139-46. View abstract
  127. Early postoperative severity of illness predicts outcomes after the stage I Norwood procedure. Ann Thorac Surg. 2011 Aug; 92(2):660-5. View abstract
  128. Gene regulation of extracellular matrix remodeling in human bone marrow stem cell-seeded tissue-engineered grafts. Tissue Eng Part A. 2011 Oct; 17(19-20):2379-88. View abstract
  129. Massive air embolism in a Fontan patient. J Extra Corpor Technol. 2011 Jun; 43(2):79-83. View abstract
  130. Postnatal left ventricular diastolic function after fetal aortic valvuloplasty. Am J Cardiol. 2011 Aug 15; 108(4):556-60. View abstract
  131. Perioperative factors associated with prolonged mechanical ventilation after complex congenital heart surgery. Pediatr Crit Care Med. 2011 May; 12(3):e122-6. View abstract
  132. Early reintervention on the pulmonary arteries and right ventricular outflow tract after neonatal or early infant repair of truncus arteriosus using homograft conduits. Am J Cardiol. 2011 Jul 01; 108(1):106-13. View abstract
  133. Anomalous left coronary artery arising from the pulmonary artery in hypoplastic left hearts: case series and review of literature. J Thorac Cardiovasc Surg. 2011 Jul; 142(1):225-7. View abstract
  134. Right ventricle and tricuspid valve function at midterm after the Fontan operation for hypoplastic left heart syndrome: impact of shunt type. Pediatr Cardiol. 2011 Feb; 32(2):160-6. View abstract
  135. Mind-body medicine in chronic heart failure: a translational science challenge. Circ Heart Fail. 2010 Nov; 3(6):715-25. View abstract
  136. Rapid-response extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in children with cardiac disease. Circulation. 2010 Sep 14; 122(11 Suppl):S241-8. View abstract
  137. Intraoperative assessment after pediatric cardiac surgical repair: initial experience with C-arm angiography. J Thorac Cardiovasc Surg. 2010 Jul; 140(1):e1-3. View abstract
  138. Electrical dyssynchrony and endocardial fibroelastosis resection in the rehabilitation of hypoplastic left cardiac syndrome. Cardiol Young. 2010 Oct; 20(5):516-21. View abstract
  139. Acute kidney injury and regional abdominal perfusion during neonatal aortic arch reconstruction. J Thorac Cardiovasc Surg. 2010 Aug; 140(2):453-8. View abstract
  140. In vivo monitoring of function of autologous engineered pulmonary valve. J Thorac Cardiovasc Surg. 2010 Mar; 139(3):723-31. View abstract
  141. Primary left ventricular rehabilitation is effective in maintaining two-ventricle physiology in the borderline left heart. J Thorac Cardiovasc Surg. 2009 Dec; 138(6):1276-82. View abstract
  142. Preoperative extracorporeal membrane oxygenation as a bridge to cardiac surgery in children with congenital heart disease. Ann Thorac Surg. 2009 Oct; 88(4):1306-11. View abstract
  143. Outcomes after anatomic repair for d-transposition of the great arteries with left ventricular outflow tract obstruction. Circulation. 2009 Sep 15; 120(11 Suppl):S53-8. View abstract
  144. Catheters, wires, tubes and drains on postoperative radiographs of pediatric cardiac patients: the whys and wherefores. Pediatr Radiol. 2008 Oct; 38(10):1041-53; quiz 1151. View abstract
  145. Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. . 2007 Nov; 293(5):R1787-97. View abstract
  146. Systolic contraction within aneurysmal rabbit myocardium following transplantation of autologous skeletal myoblasts. J Surg Res. 2006 Sep; 135(1):202-8. View abstract
  147. Catheter-mediated subselective intracoronary gene delivery to the rabbit heart: introduction of a novel method. J Gene Med. 2005 May; 7(5):595-603. View abstract
  148. Right ventricular targeted gene transfer of a beta-adrenergic receptor kinase inhibitor improves ventricular performance after pulmonary artery banding. J Thorac Cardiovasc Surg. 2004 Mar; 127(3):787-93. View abstract
  149. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Circulation. 2003 Sep 09; 108 Suppl 1:II264-71. View abstract
  150. Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. Mol Ther. 2003 Aug; 8(2):306-13. View abstract
  151. Right ventricular gene therapy with a beta-adrenergic receptor kinase inhibitor improves survival after pulmonary artery banding. Ann Thorac Surg. 2001 Nov; 72(5):1657-61. View abstract
  152. Cardiac gene delivery with cardiopulmonary bypass. Circulation. 2001 Jul 10; 104(2):131-3. View abstract
  153. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction. Circulation. 2001 Mar 06; 103(9):1311-6. View abstract